Fierce Pharma

Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer

With the program’s seventh approval in the books, the FDA is illustrating just how speedy it can be with drug reviews that ...

Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National ...

Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has approved BIZENGRI® (zenocutuzumab-zbco) for ...

FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer

The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the ...

Influencer Sydney Towle Taken to the Hospital in Ambulance amid Treatments for Rare Stage 4 Bile Duct Cancer

The content creator, 26, has been participating in a clinical trial to treat her stage 4 cholangiocarcinoma, or bile duct ...

Sydney Towle Shares Update on ‘Very Terrifying Day’ After Being Rushed to Hospital amid Treatment for Rare Cancer

Towle was first diagnosed with cholangiocarcinoma at the age of 23 ...
BioSpace

Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher

Partner Therapeutics announced last week that the FDA had granted Bizengri a Commissioner’s National Priority Voucher to ...
pharmaphorum

Partner's Bizengri is first drug for rare, aggressive cancer

Partner Therapeutics' Bizengri has been approved for a new indication, a rare form of bile duct cancer, just two days after ...

Sydney Towle Reveals She's Considering New Cancer Treatment Plans as Current One 'Probably Isn't Working'

The influencer, 26, is participating in a new clinical trial for her rare bile duct cancer ...
Healio

FDA approves Bizengri as first treatment for adults with rare bile duct cancer

The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.
Healio

Use of cholangioscopy ‘could contribute’ to improved rates of cholangiocarcinoma diagnosis

Please provide your email address to receive an email when new articles are posted on . Researchers observed a temporal association between cholangioscopy volume and subsequent cholangiocarcinoma ...
News Medical

Patient-specific "organ-on-chip" aims to accelerate research on cholangiocarcinoma

It is only a few centimeters in size and can be held between two fingers, but in the micro-channels carved inside it, it's hidden a three-dimensional and highly faithful model of a biliary tract ...